Advertisement
Screener

VANDA PHARMACEUTICALS INC. (VNDA) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

VANDA PHARMACEUTICALS INC. Increase (Decrease) in Prepaid Expense and Other Assets

VANDA PHARMACEUTICALS INC. (VNDA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $6.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • VANDA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $885.00K, a 38.37% decline year-over-year.
  • VANDA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $5.77M, a 7.01% increase year-over-year.
  • VANDA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $5.94M, a 63.43% increase year-over-year.
  • VANDA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$703.00K, a 119.20% decline year-over-year.
  • VANDA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $12.07M, a 77.04% increase from fiscal 2024.
  • VANDA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $6.82M.
  • VANDA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$8.52M, a 238.90% decline from fiscal 2022.
  • VANDA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $6.14M, a 392.06% increase from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$885.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$6.65M
10-Q · filed 2026-08-06
$12.60M
derived: sum of 3 quarters · filed 2026-08-06
$11.89M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$5.77M
10-Q · filed 2026-05-07
$11.71M
derived: sum of 2 quarters · filed 2026-05-07
$11.01M
derived: sum of 3 quarters · filed 2026-05-07
$12.45M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$5.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$5.24M
derived: sum of 2 quarters · filed 2026-02-12
$6.68M
derived: sum of 3 quarters · filed 2026-08-06
$12.07M
10-K · filed 2026-02-12
2025-09-30-$703.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$733.00K
derived: sum of 2 quarters · filed 2026-08-06
$6.12M
10-Q · filed 2025-10-30
$9.76M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$1.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$6.83M
10-Q · filed 2026-08-06
$10.46M
derived: sum of 3 quarters · filed 2026-08-06
$14.13M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$5.39M
10-Q · filed 2026-05-07
$9.03M
derived: sum of 2 quarters · filed 2026-05-07
$12.69M
derived: sum of 3 quarters · filed 2026-05-07
$13.99M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$3.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$7.30M
derived: sum of 2 quarters · filed 2026-02-12
$8.60M
derived: sum of 3 quarters · filed 2026-02-12
$6.82M
10-K · filed 2026-02-12
2024-09-30$3.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$4.96M
derived: sum of 2 quarters · filed 2025-10-30
$3.18M
10-Q · filed 2025-10-30
-$4.01M
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30$1.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$483.00K
10-Q · filed 2025-07-31
-$7.67M
derived: sum of 3 quarters · filed 2026-02-12
-$479.00K
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31-$1.78M
10-Q · filed 2025-05-08
-$8.97M
derived: sum of 2 quarters · filed 2026-02-12
-$1.78M
derived: sum of 3 quarters · filed 2026-02-12
$1.04M
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31-$7.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$4.00K
derived: sum of 2 quarters · filed 2026-02-12
$2.82M
derived: sum of 3 quarters · filed 2026-02-12
-$8.52M
10-K · filed 2026-02-12
2023-09-30$7.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$10.01M
derived: sum of 2 quarters · filed 2024-11-07
-$1.33M
10-Q · filed 2024-11-07
-$4.78M
derived: sum of 4 quarters · filed 2025-02-14
2023-06-30$2.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
-$8.53M
10-Q · filed 2024-08-01
-$11.97M
derived: sum of 3 quarters · filed 2025-02-14
-$16.08M
derived: sum of 4 quarters · filed 2025-02-14
2023-03-31-$11.35M
10-Q · filed 2024-05-09
-$14.79M
derived: sum of 2 quarters · filed 2025-02-14
-$18.90M
derived: sum of 3 quarters · filed 2025-02-14
-$18.57M
derived: sum of 4 quarters · filed 2025-02-14
2022-12-31-$3.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14
-$7.55M
derived: sum of 2 quarters · filed 2025-02-14
-$7.22M
derived: sum of 3 quarters · filed 2025-02-14
$6.14M
10-K · filed 2025-02-14
2022-09-30-$4.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$3.78M
derived: sum of 2 quarters · filed 2023-11-09
$9.58M
10-Q · filed 2023-11-09
$7.90M
derived: sum of 4 quarters · filed 2024-02-08
2022-06-30$331.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28
$13.69M
10-Q · filed 2023-07-28
$12.01M
derived: sum of 3 quarters · filed 2024-02-08
$13.38M
derived: sum of 4 quarters · filed 2024-02-08
2022-03-31$13.36M
10-Q · filed 2023-05-03
$11.68M
derived: sum of 2 quarters · filed 2024-02-08
$13.05M
derived: sum of 3 quarters · filed 2024-02-08
$14.66M
derived: sum of 4 quarters · filed 2024-02-08
2021-12-31-$1.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
-$307.00K
derived: sum of 2 quarters · filed 2024-02-08
$1.30M
derived: sum of 3 quarters · filed 2024-02-08
$1.25M
10-K · filed 2024-02-08
2021-09-30$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$2.98M
derived: sum of 2 quarters · filed 2022-11-03
$2.93M
10-Q · filed 2022-11-03
$1.76M
derived: sum of 4 quarters · filed 2023-02-09
2021-06-30$1.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$1.55M
10-Q · filed 2022-08-04
$383.00K
derived: sum of 3 quarters · filed 2023-02-09
-$3.10M
derived: sum of 4 quarters · filed 2023-02-09
2021-03-31-$50.00K
10-Q · filed 2022-05-06
-$1.22M
derived: sum of 2 quarters · filed 2023-02-09
-$4.71M
derived: sum of 3 quarters · filed 2023-02-09
-$7.64M
derived: sum of 4 quarters · filed 2023-02-09
2020-12-31-$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09
-$4.66M
derived: sum of 2 quarters · filed 2023-02-09
-$7.59M
derived: sum of 3 quarters · filed 2023-02-09
-$4.07M
10-K · filed 2023-02-09
2020-09-30-$3.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$6.42M
derived: sum of 2 quarters · filed 2021-11-04
-$2.90M
10-Q · filed 2021-11-04
-$3.09M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$2.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
$591.00K
10-Q · filed 2021-07-29
$399.00K
derived: sum of 3 quarters · filed 2022-02-24
$4.04M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$3.52M
10-Q · filed 2021-05-06
$3.33M
derived: sum of 2 quarters · filed 2022-02-24
$6.97M
derived: sum of 3 quarters · filed 2022-02-24
$6.54M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$192.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$3.44M
derived: sum of 2 quarters · filed 2022-02-24
$3.01M
derived: sum of 3 quarters · filed 2022-02-24
$2.76M
10-K · filed 2022-02-24
2019-09-30$3.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$3.20M
derived: sum of 2 quarters · filed 2020-10-29
$2.96M
10-Q · filed 2020-10-29
$3.28M
derived: sum of 4 quarters · filed 2021-02-11
2019-06-30-$434.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$681.00K
10-Q · filed 2020-08-06
-$359.00K
derived: sum of 3 quarters · filed 2021-02-11
-$166.00K
derived: sum of 4 quarters · filed 2021-02-11
2019-03-31-$247.00K
10-Q · filed 2020-05-07
$75.00K
derived: sum of 2 quarters · filed 2021-02-11
$268.00K
derived: sum of 3 quarters · filed 2021-02-11
$2.75M
derived: sum of 4 quarters · filed 2021-02-11
2018-12-31$322.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11
$515.00K
derived: sum of 2 quarters · filed 2021-02-11
$3.00M
derived: sum of 3 quarters · filed 2021-02-11
$4.26M
10-K · filed 2021-02-11
2018-09-30$193.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$2.67M
derived: sum of 2 quarters · filed 2019-11-07
$3.94M
10-Q · filed 2019-11-07
$1.31M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$2.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$3.74M
10-Q · filed 2019-08-01
$1.11M
derived: sum of 3 quarters · filed 2020-02-26
-$3.83M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$1.26M
10-Q · filed 2019-05-03
-$1.37M
derived: sum of 2 quarters · filed 2020-02-26
-$6.31M
derived: sum of 3 quarters · filed 2020-02-26
-$2.83M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31-$2.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$7.57M
derived: sum of 2 quarters · filed 2020-02-26
-$4.10M
derived: sum of 3 quarters · filed 2020-02-26
-$3.65M
10-K · filed 2020-02-26
2017-09-30-$4.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$1.47M
derived: sum of 2 quarters · filed 2018-11-07
-$1.02M
10-Q · filed 2018-11-07
-$263.00K
derived: sum of 4 quarters · filed 2019-02-19
2017-06-30$3.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$3.92M
10-Q · filed 2018-08-02
$4.68M
derived: sum of 3 quarters · filed 2019-02-19
$5.50M
derived: sum of 4 quarters · filed 2019-02-19
2017-03-31$446.00K
10-Q · filed 2018-05-02
$1.21M
derived: sum of 2 quarters · filed 2019-02-19
$2.02M
derived: sum of 3 quarters · filed 2019-02-19
$5.12M
derived: sum of 4 quarters · filed 2019-02-19
2016-12-31$760.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19
$1.58M
derived: sum of 2 quarters · filed 2019-02-19
$4.67M
derived: sum of 3 quarters · filed 2019-02-19
$6.16M
10-K · filed 2019-02-19
2016-09-30$819.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$3.92M
derived: sum of 2 quarters · filed 2017-11-08
$5.40M
10-Q · filed 2017-11-08
$1.06M
derived: sum of 4 quarters · filed 2018-02-15
2016-06-30$3.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$4.58M
10-Q · filed 2017-08-03
$246.00K
derived: sum of 3 quarters · filed 2018-02-15
$3.27M
derived: sum of 4 quarters · filed 2018-02-15
2016-03-31$1.48M
10-Q · filed 2017-05-03
-$2.85M
derived: sum of 2 quarters · filed 2018-02-15
$170.00K
derived: sum of 3 quarters · filed 2018-02-15
$4.62M
derived: sum of 4 quarters · filed 2018-02-15
2015-12-31-$4.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15
-$1.31M
derived: sum of 2 quarters · filed 2018-02-15
$3.14M
derived: sum of 3 quarters · filed 2018-02-15
$2.56M
10-K · filed 2018-02-15
2015-09-30$3.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$7.47M
derived: sum of 2 quarters · filed 2016-11-03
$6.89M
10-Q · filed 2016-11-03
$6.13M
derived: sum of 4 quarters · filed 2017-02-17
2015-06-30$4.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28
$3.87M
10-Q · filed 2016-07-28
$3.11M
derived: sum of 3 quarters · filed 2017-02-17
$2.73M
derived: sum of 4 quarters · filed 2017-02-17
2015-03-31-$581.00K
10-Q · filed 2016-05-05
-$1.34M
derived: sum of 2 quarters · filed 2017-02-17
-$1.73M
derived: sum of 3 quarters · filed 2017-02-17
-$692.00K
derived: sum of 4 quarters · filed 2017-02-17
2014-12-31-$764.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17
-$1.15M
derived: sum of 2 quarters · filed 2017-02-17
-$111.00K
derived: sum of 3 quarters · filed 2017-02-17
$318.00K
10-K · filed 2017-02-17
$290.00K
10-K · filed 2015-03-13
2014-09-30-$381.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$653.00K
derived: sum of 2 quarters · filed 2015-11-04
$1.08M
10-Q · filed 2015-11-04
$1.37M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-30$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31
$1.46M
10-Q · filed 2015-07-31
$1.75M
derived: sum of 3 quarters · filed 2016-02-12
$1.51M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-31$429.00K
10-Q · filed 2015-05-07
$720.00K
derived: sum of 2 quarters · filed 2016-02-12
$481.00K
derived: sum of 3 quarters · filed 2016-02-12
-$156.00K
derived: sum of 4 quarters · filed 2016-02-12
2013-12-31$291.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$52.00K
derived: sum of 2 quarters · filed 2016-02-12
-$585.00K
derived: sum of 3 quarters · filed 2016-02-12
-$1.26M
10-K · filed 2016-02-12
2013-09-30-$239.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-27
-$876.00K
derived: sum of 2 quarters · filed 2014-10-27
-$1.55M
10-Q · filed 2014-10-27
-$1.07M
derived: sum of 4 quarters · filed 2015-03-13
2013-06-30-$637.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
-$1.32M
10-Q · filed 2014-08-08
-$833.00K
derived: sum of 3 quarters · filed 2015-03-13
-$937.00K
derived: sum of 4 quarters · filed 2015-03-13
2013-03-31-$679.00K
10-Q · filed 2014-05-08
-$196.00K
derived: sum of 2 quarters · filed 2015-03-13
-$300.00K
derived: sum of 3 quarters · filed 2015-03-13
$640.00K
derived: sum of 4 quarters · filed 2015-03-13
2012-12-31$483.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13
$379.00K
derived: sum of 2 quarters · filed 2015-03-13
$1.32M
derived: sum of 3 quarters · filed 2015-03-13
$884.00K
10-K · filed 2015-03-13
$827.00K
10-K · filed 2013-02-26
2012-09-30-$104.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$836.00K
derived: sum of 2 quarters · filed 2013-11-08
$401.00K
10-Q · filed 2013-11-08
$240.00K
10-Q · filed 2012-11-08
$1.53M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$940.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31
$505.00K
10-Q · filed 2013-07-31
$340.00K
10-Q · filed 2012-08-03
$1.63M
derived: sum of 3 quarters · filed 2014-02-25
$1.40M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$435.00K
10-Q · filed 2013-05-10
$691.00K
derived: sum of 2 quarters · filed 2014-02-25
$456.00K
derived: sum of 3 quarters · filed 2014-02-25
$1.03M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$891.00K
derived: sum of 2 quarters · filed 2014-02-25
$1.46M
derived: sum of 3 quarters · filed 2014-02-25
$1.24M
10-K · filed 2014-02-25
2011-09-30-$235.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$338.00K
derived: sum of 2 quarters · filed 2012-11-08
$114.00K
10-Q · filed 2012-11-08
$54.00K
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30$573.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
$349.00K
10-Q · filed 2012-08-03
$289.00K
derived: sum of 3 quarters · filed 2013-02-26
$672.00K
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31-$224.00K
10-Q · filed 2012-05-09
-$284.00K
derived: sum of 2 quarters · filed 2013-02-26
$99.00K
derived: sum of 3 quarters · filed 2013-02-26
2010-12-31-$60.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$323.00K
derived: sum of 2 quarters · filed 2013-02-26
-$250.00K
10-K · filed 2013-02-26
2010-09-30$383.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
-$190.00K
10-Q · filed 2011-11-07
2010-06-30-$573.00K
10-Q · filed 2011-08-05
2009-12-31$805.00K
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Evommune, Inc. (EVMN)United States$0.320B-5.10
Upstream Bio, Inc. (UPB)United States$0.284B-2.42